1 Braunstein GD. Gynaecomastia. N Engl J Med 1993; 328: 490–5. 2 Aguirre MA, Velez A, Romero M, Collantes E. Gynaecomastia and sexual impotence associated with methotrexate treatment. J Rheumatol 2002; 29: 1793–4. 3 Callen JP. KulpShorten CL,Wolverton SE. Methotrexate. In: Wolverton, SE, ed. Comprehensive Dermatologic Drug Therapy. WB Saunders, Philadelphia, 2001: 147–164. 4 Sussman A, Leonard JM. Psoriasis, methotrexate and oligospermia. Arch Dermatol 1980; 116: 215–17. 5 Gunther VE. Andrologische Untersuchung en bei der antimetabolite therapie der Psoriasis. Dermatol Monatsschr 1970; 156: 498–502. 6 Van Scott EJ, Reinertson RP. Morphologic and physiologic effects of chemotherapeutic agents in psoriasis. J Invest Dermatol 1959; 33: 357–69. 7 Thomas E, Leroux JL, Blotman F. Gynaecomastia in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1994; 21: 1777–8. 8 Del Paine DW, Leek JC, Jakle C, Robbins DL. Gynaecomastia associated with low dose methotrexate therapy. Arthritis Rheum 1983; 26: 691–2. 9 Finger DR, Klipple GL. Gynaecomastia following low dose methotrexate therapy for rheumatoid arthiritis. J Rheumatol 1995; 22: 796–7. 10 Glass AR, Bereberg J. Gynaecomastia after chemotherapy for lymphoma. Arch Intern Med 1979; 139: 1048–9.
[1]
R. Dummer,et al.
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
,
2004,
Archives of dermatology.
[2]
G. Siller,et al.
Psoriasis induced by topical imiquimod
,
2004,
Australasian Journal of Dermatology.
[3]
R. Dummer,et al.
Imiquimod in basal cell carcinoma: how does it work?
,
2003,
The British journal of dermatology.
[4]
E. Schrumpf,et al.
Psoriasis induced by interferon‐α
,
1991
.
[5]
E. Schrumpf,et al.
Psoriasis induced by interferon-alpha.
,
1991,
The British journal of dermatology.